Abstract

Aims
Paediatric guidance on diagnosis and treatment of urinary tract infections (UTIs) has in the past largely focused on identifying children with vesicoureteral reflux, thought to be at greatest risk of renal scarring. This practice has been questioned; specifically the accepted association between UTI and end-stage renal failure (ESRF) through renal scarring. The aim of this paper is to ascertain whether we can predict with confidence the true level of risk that a child with a first time UTI will subsequently develop ESRF attributable to UTI.
Methods
Using data available from renal registries an analytical approach based on previous estimates of risk is used to demonstrate the range of plausible estimates of risk that can be generated and levels of uncertainty that surrounds those estimates.
Results
Estimates of the perceived risk of developing ESRF following UTI range from 1/154 to 1/199900 and are heavily dependent on the assumptions made and the source of data.
Conclusion
There is considerable uncertainty in the relationship between childhood UTI and risk of ESRF based on the data currently available. Until further evidence is available clinicians will continue to debate the risk of UTI and ESRF and consensus opinion will continue to guide management.
Summary
Scarring of the kidneys can lead to ESRF. Most scarring is congenital, though some is caused by childhood urinary tract infection. Invasive investigations are undertaken in the belief that infection may lead to ESRF. We show that the risk of childhood urinary tract infection leading to ESRF is highly uncertain. The routine use of invasive investigations may be unwarranted based on the strength of the current evidence.
3
Background
Urinary tract infection (UTI) is estimated to have been diagnosed in up to 11.3% of girls and 3.6% of boys by the age of 16 years in the UK(1) with recurrence common (2) . Studies from Sweden have shown incidence of first diagnoses of UTI to be around 2% of boys and girls by the age of two years and 2% and 7% by the age of six years(3;4).
Of major importance in diagnosing and treating UTI is the perceived risk of renal scarring resulting from febrile UTI, ultimately leading to end-stage renal failure (ESRF) and premature death. How often episodes of febrile UTI in childhood could lead to end-stage renal failure is of major interest as this would strongly influence the need for follow-up and radiological investigations in these children. A widely cited 1997 study, by Stark(5) , estimates that the likelihood of UTI leading to ESRF in females was 1 in every 10,000 patients. The arguments used to support this estimate are erroneous in that they use the incidence of new cases of ERSF per year, rather than prevalence. As a result, the study describes the risk of someone with a childhood UTI developing ESRF during one year, rather than the lifetime risk of developing ESRF.
The 1997 study additionally fails to account for uncertainty in the relationship between febrile UTI and renal scarring and the proportion of ESRF cases that can be attributed to UTI.
Any estimates of the risk of UTI leading to ESRF should take account of this uncertain relationship.
Using the method of analysis employed in the Stark study as a starting point, this study examines the lifetime risk of developing ESRF following a childhood UTI as well as considering the uncertainty inherent in any such estimate to determine whether we can predict with confidence the true level of risk.
Methods
Working from the information provided in the Stark study, described below are the methods used to derive the original estimates of the risk of UTI leading to ESRF of 1/10,000. The same analytic approach is then used to demonstrate, based on currently available data, the wide range of plausible estimates of risk that can be generated and therefore the significant levels of uncertainty that surrounds any estimate of risk. Estimates of risk based on the data collected across a range of countries are also calculated.
Data was collected from a range of renal registries (6) (7) (8) (9) (10) The initial, base case analysis, based on that of Stark (5), assumes for all cases of ESRF attributed to renal damage the patient has had a UTI (C=0) and secondly, that renal damage associated with VUR is the only mechanism by which UTI can lead to ESRF (D=0). These assumptions, while useful in the development of the base-case model, do not necessarily reflect the true clinical situation but are retained to allow comparison with the analysis by
Re-analysis using this method is conducted to demonstrate the wide range of plausible alternative estimates, drawing on data available from renal registries and the published literature. Stark bases his analysis on the annual incidence of ESRF, whereas the cumulative lifetime risk of developing ESRF may be more appropriate for estimating the risk of childhood UTI leading to ESRF over the course of lifetime. We show how the choice of annual incidence or cumulative incidence impacts on the estimate of risk. Estimates of risk are for females and are applied to the proportion of the cohort at risk (those who were alive and who had not already developed ESRF). Data for females is used in the first analysis to allow comparison with the estimate made by Stark(5; 11) .
The five different models tested and the source of data for each are presented in Table 1 .
The analysis by Stark is based on a mix of data from the USRDS and EDTA registries. Table 2 presents the cumulative incidence of ESRF calculated from EDTA figures. Table 3 demonstrates the risk of childhood UTI leading to ESRF based on estimates of cumulative incidence of ESRF taken from We also present an international comparison of the risk of UTI as the cause of current cases of ESRF to demonstrate how the definition of ESRF and its causes impacts on how risk may be perceived on a country by country basis. Data for this analysis is used for the total population and is based on prevalence of ESRF in the total population, as it was not possible to make like-for-like comparisons using incidence data between countries using the available published evidence (Table 4 ). Comparisons in Table 4 are based on the prevalence of ESRF across the whole population for each country. This table shows the probability that any current case of ESRF may have been associated with a UTI in childhood. Due to the differences in the way that data is reported between countries, this estimate is based on the prevalence of ESRF at all ages. This will most likely overestimate the risk of a childhood UTI leading to ESRF; however, there will still exist differences in risk estimates arising from the way in which the causes of ESRF and those patients with ESRF are defined in different countries and regions and it is the relative differences that are of importance in the comparison made in Table 4 .
Results
Discussion
In this study we found that the risk of developing ESRF following a first time UTI in females is uncertain and potentially much greater than that estimated in a previous study. Depending on the assumptions we made in our model, we found estimates of risk to vary between 1/861 to 1/3300, with an outlying value of 1/199,900 when the data from the US register USRDS was used. If the figures are calculated instead for patients with febrile UTI then the risk will be substantially higher. Jodal et al (12) found that the incidence of febrile UTI by the age of seven was 2.7% for girls, roughly one third the estimate of risk of any childhood UTI. If only febrile UTI were considered each estimate of risk given above would between three and four times greater.
It is well known that in particular circumstances UTI is associated with a risk of renal scarring (13) . This is estimated to occur in 5-15% of children within the two years of their first presentation with a febrile UTI (2) . Young children, especially infants, are assumed to be at greater risk of developing renal scarring than older children or adults. Renal scarring is known to be associated with long-term morbidities such as, pregnancy complications, chronic kidney disease and in some cases, established ESRF. End stage renal failure is irreversible and requires regular dialysis or transplantation if the individual is to survive (14) .
A major problem when calculating the risks of a UTI is the difficulty in separating congenital renal dysplasia from acquired scarring due to acute pyelonephritis. This is in many cases both clinically and scientifically a very complex differential diagnosis. It was previously believed that acquired renal scarring was very common. With the advent of prenatal ultrasound it has however become evident that much of this scarring was present at birth.
It is clear from this analysis that there are marked differences in attribution of causes of ESRF across different countries. This is related to the diagnostic difficulties mentioned above and makes it difficult to estimate the real likelihood that a childhood UTI will go on to cause ESRF. It can be reasonably assumed that although the rates of UTI leading to ESRF differ across countries, much of this difference may be attributable to the way that the causes of ESRF are defined. To avoid this ambiguity, the analyses presented here includes an international comparison to show where these differences arise and how they impact on the results. For example, in Australia and New Zealand, 3% of ESRF cases are attributed to reflux nephropathy, while in the UK, 12% of cases are attributed to pyelonephritis.
Within the analyses presented here, estimation of life-time risk of developing ESRF as a result of having had a childhood UTI is highly variable; results are highly dependent on which registry data is included in the analysis. The USRDS registry (as used in Model 3) provides the greatest detail in defining the causes of ESRF. As a result, the model based on figures from this registry provides arguably the most reliable estimate.
Stark argues that the number of patients who have a single UTI in childhood who then go on to have ESRF is very small, and that the risk of developing ESRF as a result of a childhood UTI is low 5 . This would suggest that the investigations often undertaken to diagnose VUR and renal scarring in children with first-time UTI are unwarranted and significant changes in clinical practice may be required, though such investigations may be warranted for reasons unrelated to concerns about developing long-term complications such as ESRF. If risk cannot be estimated reliably, the implications for the management of children who present with symptoms suggestive of UTI become unclear.
The confusion about the risk of a UTI highlighted in the present analyses can significantly explain the wide differences in opinion about how to manage children who have had this infection. Over the past decade there has been a strong debate that has focussed on the relationship between UTI, VUR and scarring. Venhola and Uhari (15) e.g. argue that 'the overall importance of VUR is confounded because of the natural tendency of VUR to resolve spontaneously, its dynamic nature, and its different grades in children'. In line with the recently published UK guidelines from NICE(16) which outline a less invasive programme of management, they recommend 'less unpleasant and possibly unnecessary imaging tests for VUR '(15) . This is refuted by some professionals who argue for more rather than less assiduous management given evidence and clinical anecdotes 'which indicate that scars may develop in infant kidneys quicker than urine culture can confirm the diagnosis, and that reflux nephropathy has no age limit' (17) .
Conclusion
Re Table 2 adapted from the NICE guidelines on the management of UTI in children(16) 
